DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,170
+1,390 (7.82%)
At close: Dec 5, 2025
47.46%
Market Cap 335.79B
Revenue (ttm) 149.47B
Net Income (ttm) 39.73M
Shares Out 17.52M
EPS (ttm) 2.27
PE Ratio 8,452.67
Forward PE n/a
Dividend 150.00 (0.78%)
Ex-Dividend Date Dec 29, 2025
Volume 754,984
Average Volume 216,735
Open 18,500
Previous Close 17,780
Day's Range 18,200 - 19,170
52-Week Range 9,960 - 19,170
Beta -0.29
RSI 72.65
Earnings Date Nov 11, 2025

About DAE HWA Pharmaceutical

DAE HWA Pharmaceutical Co., Ltd., a pharmaceutical company, produces and supplies pharmaceutical products in South Korea. The company offers drugs for anticancer, antibiotics, antifungal and skin ailment, antivirus, anti-allergosis, hemorrhoids, antidepressant, antiepileptic, psychotropic agent, anti respiratory, anti-inflammatory, analgesic, skeletal muscle relaxants, osteoporosis, anti-arthritis, gastro-intestinal, obesity, antispasmodic, diabetics, hypertension, hyperlipemia, antithrombotic and anticoagulant, hepatic, erectile dysfunction, u... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 308
Stock Exchange KOSDAQ
Ticker Symbol 067080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.